Daina B. Esposito

1.2k total citations
38 papers, 768 citations indexed

About

Daina B. Esposito is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Daina B. Esposito has authored 38 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Epidemiology and 10 papers in Health. Recurrent topics in Daina B. Esposito's work include SARS-CoV-2 and COVID-19 Research (12 papers), Vaccine Coverage and Hesitancy (10 papers) and COVID-19 Clinical Research Studies (6 papers). Daina B. Esposito is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), Vaccine Coverage and Hesitancy (10 papers) and COVID-19 Clinical Research Studies (6 papers). Daina B. Esposito collaborates with scholars based in United States, United Kingdom and Germany. Daina B. Esposito's co-authors include Marietta Vázquez, Eugene D. Shapiro, Isaac Benowitz, Crystal N. Holick, Stephan Lanes, Macarius Donneyong, Steven D. Nathan, Sachin N. Desai, Trung N. Tran and Penelope H. Dennehy and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Daina B. Esposito

38 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daina B. Esposito United States 14 317 231 192 114 103 38 768
Po-Po Lam Canada 9 644 2.0× 258 1.1× 294 1.5× 70 0.6× 67 0.7× 9 874
Harish Pemde India 15 118 0.4× 120 0.5× 60 0.3× 62 0.5× 65 0.6× 68 698
Lisa McHugh Australia 15 288 0.9× 79 0.3× 110 0.6× 41 0.4× 62 0.6× 38 589
Ida Laake Norway 15 313 1.0× 104 0.5× 142 0.7× 32 0.3× 87 0.8× 43 616
Srinivas Rao Valluri United States 15 137 0.4× 1.0k 4.3× 454 2.4× 275 2.4× 60 0.6× 44 1.6k
Marta López Spain 18 317 1.0× 181 0.8× 55 0.3× 69 0.6× 136 1.3× 39 882
Ami Buikema United States 14 267 0.8× 96 0.4× 125 0.7× 140 1.2× 60 0.6× 38 651
Luz María Vilca Spain 14 214 0.7× 164 0.7× 161 0.8× 59 0.5× 90 0.9× 24 592
Antonella Zizza Italy 14 309 1.0× 206 0.9× 34 0.2× 328 2.9× 27 0.3× 58 892
Dina Pfeifer United States 8 310 1.0× 157 0.7× 231 1.2× 14 0.1× 32 0.3× 10 517

Countries citing papers authored by Daina B. Esposito

Since Specialization
Citations

This map shows the geographic impact of Daina B. Esposito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daina B. Esposito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daina B. Esposito more than expected).

Fields of papers citing papers by Daina B. Esposito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daina B. Esposito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daina B. Esposito. The network helps show where Daina B. Esposito may publish in the future.

Co-authorship network of co-authors of Daina B. Esposito

This figure shows the co-authorship network connecting the top 25 collaborators of Daina B. Esposito. A scholar is included among the top collaborators of Daina B. Esposito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daina B. Esposito. Daina B. Esposito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Beck, Ekkehard, Elisha Beebe, Daina B. Esposito, et al.. (2024). Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States. Infectious Diseases and Therapy. 14(1). 199–216. 5 indexed citations
3.
4.
Bush, Christopher, Katherine E. Mues, Ekkehard Beck, et al.. (2024). Real-world comparative effectiveness of a third dose of mRNA-1273 versus BNT162b2 among adults aged ≥ 65 years in the United States. Vaccine. 42(25). 126113–126113. 4 indexed citations
5.
Nguyễn, Văn Hùng, Alina Bogdanov, Cathérine Boileau, et al.. (2024). Comparative effectiveness of the bivalent COVID-19 mRNA vaccines, mRNA1273-222 and BNT162b2, in immunocompromised adults in the US.. Journal of Clinical Oncology. 42(16_suppl). e23057–e23057. 1 indexed citations
6.
Urdaneta, Verónica, et al.. (2024). Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273. Open Forum Infectious Diseases. 11(3). ofae067–ofae067. 5 indexed citations
7.
Nguyễn, Văn Hùng, Cathérine Boileau, Alina Bogdanov, et al.. (2023). Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults. Vaccines. 11(11). 1711–1711. 17 indexed citations
8.
Nguyen, Van Hung, Cathérine Boileau, Alina Bogdanov, et al.. (2023). 2359. Relative effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines in adults at higher risk for severe COVID-19 outcomes. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
9.
Straus, Walter L., Verónica Urdaneta, Daina B. Esposito, et al.. (2022). Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide. Clinical Infectious Diseases. 76(3). e544–e552. 22 indexed citations
10.
Mues, Katherine E., Deesha Patel, L. Scott Chavers, et al.. (2022). Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States. Vaccine. 40(47). 6730–6739. 10 indexed citations
11.
12.
Esposito, Daina B., Geetanjoli Banerjee, Leo Russo, et al.. (2019). Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data. SHILAP Revista de lepidopterología. 2019. 1–5. 7 indexed citations
13.
14.
Esposito, Daina B., Leo Russo, Ruihua Yin, et al.. (2019). Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims database. Cancer Epidemiology. 61. 30–37. 11 indexed citations
15.
Esposito, Daina B., Lina Titievsky, Daniel C. Beachler, et al.. (2018). Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population. Vaccine. 36(52). 8084–8093. 9 indexed citations
16.
Esposito, Daina B., Stephan Lanes, Macarius Donneyong, et al.. (2015). Idiopathic Pulmonary Fibrosis in United States Automated Claims: Incidence, Prevalence, and Algorithm Validation. American Journal of Respiratory and Critical Care Medicine. 192(10). 1200–1207. 83 indexed citations
17.
Carbonari, Dena M., Craig Newcomb, Kevin Haynes, et al.. (2015). Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs. BMC Pharmacology and Toxicology. 16(1). 8–8. 7 indexed citations
18.
Esposito, Daina B., Linda Nelsen, Crystal N. Holick, et al.. (2014). Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients. European Respiratory Journal. 44(Suppl 58). P3472–P3472. 2 indexed citations
19.
Hustedt, Joshua W., et al.. (2012). Seroepidemiology of Human Bocavirus Infection in Jamaica. PLoS ONE. 7(5). e38206–e38206. 18 indexed citations
20.
Benowitz, Isaac, et al.. (2010). Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their Infants. Clinical Infectious Diseases. 51(12). 1355–1361. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Po-Po Lam Breakdown of academic impact, for papers by Harish Pemde Breakdown of academic impact, for papers by Lisa McHugh Breakdown of academic impact, for papers by Ida Laake Breakdown of academic impact, for papers by Srinivas Rao Valluri Breakdown of academic impact, for papers by Marta López Breakdown of academic impact, for papers by Ami Buikema Breakdown of academic impact, for papers by Luz María Vilca Breakdown of academic impact, for papers by Antonella Zizza Breakdown of academic impact, for papers by Dina Pfeifer
Rankless by CCL
2026